EnsembleIQ Launches GLP-1 Shopper Summit Amid Rapid Consumer Behavior Shift — EnsembleIQ

Event summary

EnsembleIQ launches GLP-1 Shopper Summit on November 12, 2026 in Chicago to address significant shifts in consumer behavior due to GLP-1 medication adoption.
Households using GLP-1 medications account for 23% of U.S. households and are projected to represent 35% of all food and beverage units sold by 2030, according to Circana.
The summit will bring together senior leaders from retail, CPG, data, and technology organizations to examine changes in shopper behavior and business growth strategies.

The big picture

EnsembleIQ's GLP-1 Shopper Summit highlights a fundamental shift in shopper behavior driven by the rapid adoption of GLP-1 medications. This transformation is reshaping categories, retail strategies, and growth opportunities across the industry. The event aims to provide data-driven insights and practical strategies for responding to these changes.

What we're watching

Consumer Behavior Shift: How GLP-1 adoption will continue to reshape food purchasing patterns, basket composition, and category performance.
Retail Strategy: Whether retailers and brands can effectively respond to the changing consumer priorities around health and wellness.
Product Innovation: The pace at which consumer brands will innovate their product portfolios to meet the demands of GLP-1 users seeking more protein, fiber, and healthy fats.